Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice

Suramin is a polysulfonated derivative of urea and has been widely used both to treat infections and as a chemotherapeutic drug. Suramin has been shown to inhibit growth factor signaling pathways; however, its effect on apoptosis is unknown. Here we show that suramin inhibits apoptosis induced throu...

Full description

Saved in:
Bibliographic Details
Main Authors: Eichhorst, Sören (Author) , Golks, Alexander (Author) , Krammer, Peter H. (Author)
Format: Article (Journal)
Language:English
Published: 16 May 2004
In: Nature medicine
Year: 2004, Volume: 10, Issue: 6, Pages: 602-609
ISSN:1546-170X
DOI:10.1038/nm1049
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/nm1049
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/nm1049
Get full text
Author Notes:Sören T. Eichhorst, Andreas Krueger, Susanne Müerköster, Stefanie C. Fas, Alexander Golks, Uwe Gruetzner, Louise Schubert, Christine Opelz, Manfred Bilzer, Alexander L. Gerbes & Peter H. Krammer
Description
Summary:Suramin is a polysulfonated derivative of urea and has been widely used both to treat infections and as a chemotherapeutic drug. Suramin has been shown to inhibit growth factor signaling pathways; however, its effect on apoptosis is unknown. Here we show that suramin inhibits apoptosis induced through death receptors in hepatoma and lymphoma cells. It also inhibits the proapoptotic effect of chemotherapeutic drugs. The antiapoptotic mechanism is specific to cell type and is caused by reduced activation, but not altered composition, of the death-inducing signaling complex (DISC), and by inhibition of the initiator caspases 8, 9 and 10. Suramin also shows similar effects in in vivo models: apoptotic liver damage induced by CD95 stimulation and endotoxic shock mediated by tumor-necrosis factor (TNF) are inhibited in mice, but necrotic liver damage is not inhibited in a rat model of liver transplantation. Thus, the antiapoptotic property of suramin in the liver may be therapeutically exploited.
Item Description:Gesehen am 06.04.2021
Physical Description:Online Resource
ISSN:1546-170X
DOI:10.1038/nm1049